Nevada Regents OK landmark UNR Med-Renown Health deal

A student walks on the University of Nevada, Reno campus on Tuesday, Aug. 25, 2020.

A student walks on the University of Nevada, Reno campus on Tuesday, Aug. 25, 2020. Photo: David Calvert / The Nevada Independent


The Board of Regents met for two days last week to hash out a host of higher education issues in the wake of a busy legislative session that saw operational budgets slashed even as personnel budgets were spared.

The result was a whirlwind of new approved policies, among them finalizing a major partnership deal for the UNR School of Medicine with Reno-area healthcare giant Renown Health.


Roughly 10 months 
after initial negotiations began on a partnership deal, regents voted 12-1 to approve a landmark agreement that will tie the two parties together for the next 50 years.

The final vote Friday came after a months-long process of votes across different bodies, with the deal clearing both Renown’s corporate board and the Legislature.

Regents, administrators and Renown executives have hailed the agreement as “transformative,” and a major step in expanding the scope of UNR’s medical programs, teaching programs and clinical research.

“We are one of the last medical schools to be community-based, as we are now,” UNR Med Dean Tom Schwenk said.

Schwenk said the lack of any public-private agreement limited the school’s ability to expand clinical research, expand class sizes and build new residency programs, all reasons why “every medical school in the country has pursued this type of health system partnership.”

Still, some regents raised concerns over the half-century length of the deal — the first of its kind in Nevada — as well as over provisions that could trigger the sale of the medical school’s clinical research department under certain conditions.


As written, the deal would allow Renown to terminate the agreement if the sum of state funding and student tuition money dropped by 20 percent or more in a single year. Under those conditions, the clause would give Renown a right of first offer to purchase UNR Medical School’s basic science and clinical research departments.


Coupled with the lengthy timeline, Board Chair Mark Doubrava said that while he supported the effort from a “medical education standpoint,” the sale clause could prove to be an unintended landmine should economic downturns or unexpected inflation shifts trigger the fine print of the agreement.


“This could potentially serve as a template for UNLV when they do their associations, so that means we have to get this one right,” Doubrava said.


Doubrava — an ophthalmologist who earned his medical degree from UNR in 1989 — was ultimately the sole vote against approval, saying afterward that his objection was “just an issue of contracts.”


Still, all other board members expressed approval of the language as written, deferring in part to UNR President Brian Sandoval’s description of the clause as a “safety net” that would protect the school in a worst-case scenario, rather than a mechanism by which Renown would privatize the school.


“The intent of it was that, in the very unlikely event there was a dramatic reduction in funding which would lend itself to a closure of the clinic facilities — this was an effort on behalf of Renown to try and keep the doors open,” Sandoval told regents. “And it would be subject to the review and approval of the regents, and so I think that was just a safety clause.”


Jacob Solis is a staff writer with The Nevada Independent, a 501(c)3 nonprofit news organization. The following people or entities mentioned in this article are financial supporters of The Indy: Brian Sandoval - $900.00. This 
story was first published June 11 and is republished here with permission. For more Nevada news, including wall-to-wall reporting on the Legislature, visit The Nevada Independent.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment